Armis Advisers’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$410K Sell
29,901
-3,176
-10% -$49.1K 0.03% 318
2026
Q2
$529K Buy
33,077
+503
+2% +$7.72K 0.05% 264
2026
Q1
$512K Buy
32,574
+536
+2% +$7.9K 0.05% 243
2025
Q4
$457K Sell
32,038
-9,494
-23% -$137K 0.05% 243
2025
Q3
$611K Sell
41,532
-1,570
-4% -$23.5K 0.06% 176
2025
Q2
$655K Buy
43,102
+17,657
+69% +$258K 0.05% 242
2025
Q1
$366K Buy
+25,445
New +$389K 0.03% 285

Other funds holding BCAT

Armis Advisers's BCAT Position: Q3 2026 in Review

Armis Advisers reduced its BlackRock Capital Allocation Term Trust (BCAT) stake by 9.6% in Q3 2026, selling an estimated $49.1K and leaving 29,901 shares worth $410K. The position accounts for 0.03% of the portfolio, ranked #318.

Armis Advisers first reported a position in BCAT in Q1 2025 and has held it in 7 quarters since. The position peaked at $655K in Q2 2025. 10 funds tracked by Wall St. Rank hold BCAT as of Q3 2026.

  • Armis Advisers held 29,901 shares of BlackRock Capital Allocation Term Trust worth $410K as of Q3 2026.
  • Armis Advisers sold 3,176 BlackRock Capital Allocation Term Trust shares in Q3 2026, an estimated $49.1K.
  • BlackRock Capital Allocation Term Trust made up 0.03% of Armis Advisers's portfolio in Q3 2026, its #318 holding.
  • Armis Advisers first reported a position in BlackRock Capital Allocation Term Trust in Q1 2025 and has held it in 7 quarters since.
  • Armis Advisers's BlackRock Capital Allocation Term Trust position peaked at $655K in Q2 2025.
  • 10 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2026.

Based on Armis Advisers's 13F filing for Q3 2026, filed 13 Oct 2026.